Revvity, Inc. (RVTY)
Valuation Overview•Is Revvity, Inc. Overvalued or Undervalued?
Market price has outpaced base-case intrinsic cash flows, pricing in significant future growth optimism.
Moderate quality score of 48/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street is broadly bullish, projecting solid upside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
RVTY demonstrates adequate business quality with stable profitability. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company is facing top-line contraction (-4.8% 3Y CAGR) however, earnings have severely contracted over the same period. Operating efficiency remains adequate with margins around 12.4%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $711.1M | +3.7% | -4.8% | -5.5% | +3.1% | |
| EBITDA | $180.9M | — | -18.3% | — | — | |
| Net Income | $40.7M | -18.3% | -24.8% | — | +1.3% | |
| EPS (Diluted) | $0.36 | -13.7% | -22.7% | -20.4% | +1.0% | |
| Free Cash Flow | $106.1M | -6.2% | -5.1% | -9.3% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 51.4% | 49.7% | 52.4% | 49.6% |
| Operating Margin | 12.4% | 14.0% | 20.1% | 18.3% |
| Net Margin | 8.3% | 5.0% | 11.3% | 10.9% |
| FCF Margin | 17.4% | 12.6% | 18.1% | 15.6% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $1.02 | $1.06 | +3.9% | ||
| Q1'26 | $1.57 | $1.70 | +8.3% | ||
| Q4'25 | $1.14 | $1.18 | +3.5% | ||
| Q3'25 | $1.14 | $1.18 | +3.5% | ||
| Q2'25 | $0.96 | $1.01 | +5.2% | ||
| Q1'25 | $1.37 | $1.42 | +3.6% | ||
| Q4'24 | $1.13 | $1.28 | +13.3% | ||
| Q3'24 | $1.12 | $1.22 | +8.9% |
Total return is +6.2% (1Y), lagging the benchmark by -18.8%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +2.0% | -7.3% | — |
| 1Y | +6.2% | -18.8% | +0.3% |
| 3YCAGR | -4.6% | -24.8% | +0.7% |
| 5YCAGR | -7.6% | -20.4% | +0.9% |
| 10YCAGR | +6.8% | -6.9% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Revvity, Inc. (RVTY) valuation, health, and returns.
Revvity, Inc. is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Fair versus peers compared to industry peers. overvalued (implying -21.5% downside from DCF intrinsic value of $78.50)
Revvity, Inc. has multiple valuation anchors: DCF Intrinsic Value: $78.50 | Peer Relative Fair Value: $100.35 | Wall Street Analyst Target: $109.83 (implying +9.8% upside). A convergence of these signals offers higher conviction.
Revvity, Inc. displays fair financial health with a composite quality score of 48/100, supported by a Altman Z-Score of 1.4 (distress zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 2.7%.
Revvity, Inc. pays a 0.3% dividend yield, covered by a 14% payout ratio with 0 years of growth, supplemented by a 7.3% buyback yield.
Revvity, Inc.'s current growth trajectory is Accelerating. The company achieved +3.7% 1Y revenue growth and -13.7% 1Y EPS growth, compared to its 3Y revenue CAGR of -4.8%.
Wall Street consensus is Buy based on 29 analysts, beating EPS expectations in 92% of recent quarters with a 10-quarter streak. The consensus price target represents a +9.8% change from current levels.
Investment risks for Revvity, Inc. include: -30.1% 1-year max drawdown, high beta (1.46x market volatility), elevated distress risk. Volatility risk is characterized by a beta of 1.46x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.